Skip to main content
2054 search results for:

Treatment 

sort by |
"newest" sorts results by publication date. "most relevant" also considers factors like how often the search phrase is in the result.
  1. 07-12-2022 | Rheumatoid arthritis | News | Article

    Similar reduction in CV risk with different add-on RA treatments

    “[T]he 7%–9% reduction in the arterial FDG signal that was seen in both treatment arms is similar to the signal reduction previously achieved with 10 mg atorvastatin,” point out the researchers.

  2. 28-11-2022 | Rheumatoid arthritis | News | Article

    Treatment goals in late-onset RA should match those for younger patients

    People with late-onset rheumatoid arthritis have a similar likelihood of achieving remission as those with earlier-onset disease, indicating that treatment goals should be the same in both populations, researchers report.

  3. 16-11-2022 | ACR 2022 | Conference coverage | Article

    PD-1 receptor agonist may represent a novel treatment for patients with RA

    In terms of safety, overall rates of treatment-emergent adverse events (TEAEs) were similar across treatment groups, at 32.0% in the 300 mg group, 28.6% in the 700 mg group, and 37.5% in the placebo arm during weeks 0–12.

  4. 17-08-2022 | Spondyloarthropathies | News | Article

    Infliximab potential treatment option for juvenile-onset spondyloarthritis

    Infliximab appears efficacious for patients with juvenile-onset spondyloarthritis who have failed to respond to conventional treatment, phase 3 study findings show.

  5. 11-07-2022 | Psoriatic arthritis | News | Article
    guidelinesWatch

    GRAPPA issues updated PsA treatment guidelines

    The authors provide a treatment schema summarizing their recommendations for all the different domains of PsA and related conditions.

  6. 15-06-2022 | Rheumatoid arthritis | News | Article

    Molecular signatures could help guide RA treatment selection

    An in-depth molecular analysis of synovial biopsies from people with rheumatoid arthritis who participated in the R4RA trial has identified gene signatures associated with treatment response.

  7. 08-07-2022 | Rheumatoid arthritis | News | Article

    TNF inhibitors linked to higher psoriasis risk than other RA treatments

    Treatment with TNF inhibitors is associated with a twofold increased risk for new-onset psoriasis compared with nonbiologic agents, suggest findings from a Danish cohort study.

  8. 04-06-2022 | EULAR 2022 | Conference coverage | Article

    Sarilumab shows treatment promise in relapsing polymyalgia rheumatica

    Phase 3 SAPHYR study findings suggest that the IL-6 receptor inhibitor sarilumab with glucocorticoid taper is an efficacious treatment option for patients with steroid-resistant polymyalgia rheumatica.

  9. 02-06-2022 | EULAR 2022 | Conference coverage | Article

    Topical alkalinizing treatment shows potential for acute gout

    A transdermal alkalinizing and pain-relieving treatment has been shown to effectively reduce the pain intensity and duration of an acute gout flare in the phase 2 TARGET study.

  10. 06-06-2022 | EULAR 2022 | Conference coverage | Article

    DMARD treatment has ‘profound anticoagulant effects’ in early RA

    Analysis of data from the NORD-STAR study suggests that people with early rheumatoid arthritis have increased levels of coagulation biomarkers, putting them at increased risk for venous thromboembolism, and initial treatment with DMARDs can help reduce this imbalance.

  11. 01-06-2022 | EULAR 2022 | Conference coverage | Article

    BE MOBILE trials support bimekizumab for the treatment of axSpA

    The results of two phase 3 studies suggest that dual inhibition of IL-17A and IL-17F with bimekizumab may represent a promising treatment option for nonradiographic axial spondyloarthritis and ankylosing spondylitis.

  12. 29-04-2022 | Psoriatic arthritis | News | Article

    IL-22 levels may guide PsA treatment selection

    They identified 17 patients that had received strategic treatment, ie, an IL-17 inhibitor if they had low IL-22 and a TNF inhibitor if they had high IL-22, and a further 17 patients who received mismatched treatment (n=17).

  13. 22-04-2022 | Psoriatic arthritis | News | Article
    News in brief

    Support for PsA treatment selection according to predominant clinical manifestation

    “Faced with a multitude of therapeutic options, these study results could help clinicians tailor treatment choice according to different domains of disease and provides additional evidence for developing patient-centred treatment guidelines,” conclude Sawyer and team. medwireNews is an independent medical news service provided by Springer Healthcare Ltd. © 2022 Springer Healthcare Ltd, part of the Springer Nature Group RMD Open 2022; 8 : e002074

  14. 24-03-2022 | Kawasaki disease | News | Article

    Network meta-analysis rates treatments for Kawasaki disease

    In fact, the only significant differences in fever duration versus standard therapy occurred among children who were given low-dose IVIG (100–400 mg) plus aspirin or aspirin alone.

  15. 26-04-2022 | BSR 2022 | Conference coverage | Article
    News in brief

    COVID-19: Support for pausing rituximab, considering other treatments in people with RA

    Study findings presented at the British Society for Rheumatology 2022 Annual Conference in Glasgow, UK, provide support for pausing or delaying rituximab and considering other treatment options for people with rheumatoid arthritis during the COVID-19 pandemic.

  16. 15-03-2022 | Juvenile idiopathic arthritis | News | Article
    guidelinesWatch

    ACR issues two updated guidelines for JIA treatment

    The authors also address treatment tapering and discontinuation in patients with inactive systemic JIA, as well as other aspects of JIA management, such as factors impacting treatment choice.

  17. 25-03-2022 | Systemic sclerosis | Adis Journal Club | Article
    Rheumatology and Therapy

    Photobiomodulation Therapy: A New Light in the Treatment of Systemic Sclerosis Skin Ulcers

    Complete healing of SU was recorded in 41.6% cases during EmoLED® treatment.

  18. 28-03-2022 | Rheumatoid arthritis | News | Article

    BMI not a factor for TNF vs non-TNF inhibitor treatment efficacy in RA

    Patients with rheumatoid arthritis may be at a greater risk for poor treatment responses if they are obese or underweight regardless of whether they are taking a tumor necrosis factor inhibitor or an alternative biologic, research indicates.

  19. 17-01-2022 | Giant cell arteritis | News | Article

    Weight gain during glucocorticoid use may signal treatment success in giant cell arteritis

    But they also report that “a modest increase in BMI may actually be an indicator of effective disease control regardless of treatment regimen.”

  20. 15-12-2021 | Rheumatoid arthritis | News | Article

    Looking beyond sociodemographic, clinical factors for predicting RA treatment adherence

    Psychologic, communicational, and logistic factors are the main determinants of treatment adherence among patients with rheumatoid arthritis, study findings suggest, highlighting the impact of both patient- and physician-related factors on adherence.

Filter search results

Search Operators:

„ ... ... “ Finds documents with exactly this word group, in exactly this word order and spelling (e.g., "employer branding").
AND Finds documents with both search terms (e.g., sales AND bonus).
OR Finds documents with one or the other search term (e.g., porsche OR volkswagen).
Blank Space Finds documents with all search terms. Blank space is understood as AND (e.g., man robot production).
NOT Finds documents with no appearance of the word behind NOT (e.g., ford NOT "harrison ford").
COUNT(...)>n Finds documents where the search term is mentioned at least "n" times."n" may be any number (e.g., COUNT(gear)>8).
NEAR(..., ..., ) Finds documents with both search terms in any word order, permitting "n" words as a maximum distance between them. Best choose between 15 and 30 (e.g., NEAR(recruit, professionals, 20)).
* Finds documents with the search term in word versions or composites. The star * marks whether you wish them BEFORE, BEHIND, or BEFORE and BEHIND the search term (e.g., lightweight*, *lightweight, *lightweight*).
? Finds documents with the search termn in different spellings."?" allows only one character (e.g., organi?ation).
& + - Special characters are understood as AND (e.g., Miller Bros. & Sons).

You can use operators in your search query to narrow down your results even more.

Tap the operator, or hover the mouse pointer over it, to read more about how it works.